FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

28321000087104: Antigen of Influenza B virus non-live (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2020. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
142931000087114 Antigen of Influenza B virus non-live (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
142941000087115 Antigen of Influenza B virus non-live en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

10 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antigen of Influenza B virus non-live (substance) est un(e) (attribut) antigène du virus de l'influenza B true Inferred relationship Some
Antigen of Influenza B virus non-live (substance) est un(e) (attribut) Antigen of Influenza virus non-live (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Antigen of Influenza B virus Yamagata lineage non-live (substance) est un(e) (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some
Inf FLUAD Pediatric SEQ a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus high dose each non-live antigen in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
FLUZONE High-Dose 60 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Inf AGRIFLU SEQ a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus low dose each non-live antigen in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Intanza 9 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Inf FLUAD SEQ a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Agriflu 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Antigen of Influenza B virus Victoria lineage non-live (substance) est un(e) (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some
Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
FLUZONE suspension for injection Sanofi Pasteur SA (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
FLUAD 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Inf INFLUVAC BGP a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Antigen of Influenza B virus non-live (substance) Inferred relationship Some 3

This concept is not in any reference sets

Back to Start